World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT00199732
Date of registration: 14/09/2005
Prospective Registration: No
Primary sponsor: University Hospital, Limoges
Public title: Evaluation of cccDNA and Total HBV DNA Kinetics in Lymphocytes, Total Blood and Serum in Chronic Hepatitis B Patients Treated With Adefovir Dipivoxil and Peg Interferon Alpha 2a DNA-EVAL
Scientific title: Evaluation of cccDNA and Total HBV DNA Kinetics in Lymphocytes, Total Blood and Serum in Chronic Hepatitis B Patients Treated With Adefovir Dipivoxil and Peg Interferon Alpha 2a
Date of first enrolment: December 2004
Target sample size: 19
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT00199732
Study type:  Observational
Study design:  Time Perspective: Prospective  
Phase:  N/A
Countries of recruitment
France
Contacts
Name:     Véronique Loustaud-Ratti, MD
Address: 
Telephone:
Email:
Affiliation:  University Hospital, Limoges
Key inclusion & exclusion criteria

Inclusion Criteria:

- Male and female patients >18 years of age and <70 years of age

- Patients AgHbs+ and AgHbe+ or AgHbe-, and B viral DNA >104 copies/ml PCR COBAS
MONITOR

- Patients treated with adefovir dipivoxil and peg interferon alpha 2a

- Chronic liver disease consistent with chronic hepatitis B infection on a biopsy
obtained within the past 24 months

- Naïve patients or patients having a relapse or a therapeutic failure after
monotherapy lamivudine or interferon, or bitherapy interferon alpha-lamivudine

Exclusion Criteria:

- Co-infection HIV, HCV



Age minimum: 18 Years
Age maximum: 70 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Chronic Hepatitis B
Intervention(s)
Primary Outcome(s)
Kinetic cccDNA [Time Frame: 6 months]
Secondary Outcome(s)
Secondary ID(s)
I04002
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Hoffmann-La Roche
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history